ArticleslgStudy

biology

Pulmonary capillary hemangiomatosis

Pulmonary capillary hemangiomatosis is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pulmonary capillary hemangiomatosis rather than just read about it. In short: Pulmonary capillary hemangiomatosis (PCH) is a disease affecting the blood vessels of the lungs, where abnormal capillary proliferation and venous fibrous intimal thickening result in progressive increase in vascular resistance. It is a rare cause of pulmonary hypertension, and occurs predominantly in young adults.

Pulmonary capillary hemangiomatosis — main illustration
Pulmonary capillary hemangiomatosis — illustration

Key takeaways

  • Pulmonary capillary hemangiomatosis belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pulmonary capillary hemangiomatosis to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pulmonary capillary hemangiomatosis from memory before moving on to harder problems.

Reference excerpt

Pulmonary capillary hemangiomatosis (PCH) is a disease affecting the blood vessels of the lungs, where abnormal capillary proliferation and venous fibrous intimal thickening result in progressive increase in vascular resistance. It is a rare cause of pulmonary hypertension, and occurs predominantly in young adults. Together with pulmonary veno-occlusive disease, PCH comprises WHO Group I' causes for pulmonary hypertension. Indeed, there is some evidence to suggest that PCH and pulmonary veno-occlusive disease are different forms of a similar disease process.

Signs and symptoms Nonspecific symptoms like fatigue, coughing, chest pain, and shortness of breath are what define clinical features.

Causes At least some cases appear to be due to mutations in the eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4) gene. This condition has been reported in patients with Ehlers Danlos syndrome, and scimitar syndrome.

Diagnosis Pulmonary artery hypertension, which manifests as enlarged pulmonary arteries, is a common imaging characteristic of pulmonary capillary hemangiomatosis. Additionally, as pulmonary artery hypertension worsens, typical CT imaging findings of right ventricular hypertrophy, leftward interventricular septum bowing, right atrial enlargement, and reflux of IV contrast into the inferior vena cava and hepatic veins can indicate secondary right heart dysfunction.

Treatment The only definitive treatment for this condition currently is lung transplantation. Imatinib may be of use. Epoprostenol does not appear to be of use.

Epidemiology The prevalence of this disease is estimated to be < 1/million. The usual age at presentation is between 20 and 40 but it has been reported in the newborn.

History This condition was first described in 1978.

Outcome Median survival without treatment is 3 years.

Animals This condition has been reported in cats. and dogs.

References

External links

Illustrations

Pulmonary capillary hemangiomatosis illustration

Worked examples

Example 1 — a first encounter with Pulmonary capillary hemangiomatosis

Start with the simplest possible case. Write down what Pulmonary capillary hemangiomatosis claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pulmonary capillary hemangiomatosis before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pulmonary capillary hemangiomatosis ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pulmonary capillary hemangiomatosis

In research
Pulmonary capillary hemangiomatosis appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pulmonary capillary hemangiomatosis in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pulmonary capillary hemangiomatosis is common in secondary-school and first-year university syllabi. It links to neighbouring topics Lung disorders, Pulmonology, Rare diseases, so understanding it makes those chapters shorter.
In everyday life
Look for Pulmonary capillary hemangiomatosis outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pulmonary capillary hemangiomatosis” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pulmonary capillary hemangiomatosis in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pulmonary capillary hemangiomatosis means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pulmonary capillary hemangiomatosis out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pulmonary capillary hemangiomatosis in simple terms?

Pulmonary capillary hemangiomatosis (PCH) is a disease affecting the blood vessels of the lungs, where abnormal capillary proliferation and venous fibrous intimal thickening result in progressive increase in vascular resistance. It is a rare cause of pulmonary hypertension, and occurs predominantly…

Why does Pulmonary capillary hemangiomatosis matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pulmonary capillary hemangiomatosis?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pulmonary capillary hemangiomatosis.

Tags

  • Lung disorders
  • Pulmonology
  • Rare diseases

Keep exploring